A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection

BACKGROUND: The previous formulation of epoetin alfa in Japan was a citrate-buffered protein solution containing gelatin hydrolysate as the protein protective agent. To eliminate pain at injection sites, and the risks of anaphylactic shock and unknown infections by gelatin we have developed a new fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Togawa, Akashi, Tanaka, Takanori, Nagashima, Satoru, Keta, Hiroyuki, Kobayashi, Yasue, Nishikawa, Yasuhiro, Yanai, Masanobu, Tanaka, Hideji
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2004
Assuntos:
Pharmacokinetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884567/
https://ncbi.nlm.nih.gov/pubmed/15327586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2004.02151.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados